BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26201398)

  • 1. Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan.
    Nagao Y; Urabe C; Nakamura H; Hatano N
    Epidemiol Infect; 2016 Feb; 144(3):478-92. PubMed ID: 26201398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus, adeno-associated virus and Kawasaki disease.
    Shike H; Shimizu C; Kanegaye JT; Foley JL; Schnurr DP; Wold LJ; Burns JC
    Pediatr Infect Dis J; 2005 Nov; 24(11):1011-4. PubMed ID: 16282942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing fertility rate correlates with the chronological increase and geographical variation in incidence of Kawasaki disease in Japan.
    Nagao Y
    PLoS One; 2013; 8(7):e67934. PubMed ID: 23861836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of anti-coronavirus disease 2019 policies on 10 pediatric infectious diseases.
    Yamamoto-Kataoka S; Kataoka Y; Tochitani K; Miyakoshi C; Yamamoto Y
    Pediatr Int; 2022 Jan; 64(1):e14958. PubMed ID: 34388287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease: A brief history.
    Burns JC; Kushner HI; Bastian JF; Shike H; Shimizu C; Matsubara T; Turner CL
    Pediatrics; 2000 Aug; 106(2):E27. PubMed ID: 10920183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
    Iio K; Matsubara K; Miyakoshi C; Ota K; Yamaoka R; Eguchi J; Matsumura O; Okutani T; Ueda I; Nishiyama M
    BMJ Paediatr Open; 2021; 5(1):e001034. PubMed ID: 33884312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.
    Hara T; Furuno K; Yamamura K; Kishimoto J; Mizuno Y; Murata K; Onoyama S; Hatae K; Takemoto M; Ishizaki Y; Kanno S; Sato K; Motomura Y; Sakai Y; Ohga S; Yashiro M; Nakamura Y; Hara T
    JAMA Netw Open; 2021 Apr; 4(4):e214475. PubMed ID: 33822065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the etiology of Kawasaki disease based on the changes in symptomatology and morbidity among various age groups--on validity of the streptococcal infection theory].
    Yamamoto T
    Nihon Rinsho; 1983 Sep; 41(9):1994-2004. PubMed ID: 6663737
    [No Abstract]   [Full Text] [Related]  

  • 9. Kawasaki disease: what is the epidemiology telling us about the etiology?
    Burgner D; Harnden A
    Int J Infect Dis; 2005 Jul; 9(4):185-94. PubMed ID: 15936970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic.
    Ishii T; Nawa N; Hosokawa S; Morio T; Fujiwara T
    J Med Virol; 2024 May; 96(5):e29660. PubMed ID: 38727136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic features of Kawasaki disease: Winter versus summer.
    Ozeki Y; Yamada F; Kishimoto T; Yashiro M; Nakamura Y
    Pediatr Int; 2017 Jul; 59(7):821-825. PubMed ID: 28387988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012.
    Sano T; Makino N; Aoyama Y; Ae R; Kojo T; Kotani K; Nakamura Y; Yanagawa H
    Pediatr Int; 2016 Nov; 58(11):1140-1145. PubMed ID: 26940079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease associated with chickenpox: report of two sibling cases.
    Lee DH; Huang HP
    Acta Paediatr Taiwan; 2004; 45(2):94-6. PubMed ID: 15335119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of streptococcal infection in the pathogenesis of Kawasaki disease.
    Shen CT; Wu HY; Wang NK; Huang CS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(3):144-50. PubMed ID: 2275373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.
    Makino N; Nakamura Y; Yashiro M; Ae R; Tsuboi S; Aoyama Y; Kojo T; Uehara R; Kotani K; Yanagawa H
    J Epidemiol; 2015; 25(3):239-45. PubMed ID: 25716368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of standardization of surveillance data 1). Significance of "corrected value of patients" and its application to exanthema subtium and erythema infectiosum].
    Hamamura N
    Kansenshogaku Zasshi; 1993 Jun; 67(6):515-23. PubMed ID: 8336005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative incidence of Kawasaki disease in Japan.
    Nakamura Y; Yashiro M; Yamashita M; Aoyama N; Otaki U; Ozeki Y; Sano T; Kojo T; Ae R; Aoyama Y; Makino N; Kotani K
    Pediatr Int; 2018 Jan; 60(1):19-22. PubMed ID: 29095541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992.
    Yanagawa H; Yashiro M; Nakamura Y; Kawasaki T; Kato H
    Pediatrics; 1995 Apr; 95(4):475-9. PubMed ID: 7700743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critique on the streptococcal infection theory for the cause of Kawasaki disease].
    Yanase Y
    Nihon Rinsho; 1983 Sep; 41(9):2057-62. PubMed ID: 6363751
    [No Abstract]   [Full Text] [Related]  

  • 20. Kawasaki disease: epidemiology and the lessons from it.
    Nakamura Y
    Int J Rheum Dis; 2018 Jan; 21(1):16-19. PubMed ID: 29115029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.